dear
editor
korea
suffer
outbreak
middl
east
respiratori
syndrom
coronaviru
merscov
may
endem
largest
occur
outsid
saudi
arabia
current
cur
treatment
mer
unavail
passiv
immunotherapi
use
convalesc
plasma
recov
patient
suggest
posit
clinic
effect
howev
use
human
plasma
potenti
risk
includ
anaphylact
shock
transfusionassoci
circulatori
overload
taco
transfusionrel
acut
lung
injuri
trali
describ
experi
administ
convalesc
plasma
infus
mer
patient
result
possibl
trali
might
acceler
pulmonari
manifest
mer
patient
previous
healthi
male
subject
contact
mer
patient
may
develop
symptom
product
cough
fever
june
admit
evalu
confirm
merscov
detect
upe
gene
merscov
realtim
polymeras
chain
reaction
qpcr
assay
kogen
biotech
seoul
korea
treat
oral
administr
ribavirin
lopinavirritonavir
singl
dose
interferon
howev
patient
clinic
manifest
show
stagnant
cours
therefor
convalesc
plasma
therapi
plan
convalesc
plasma
donor
cure
femal
patient
previou
histori
gestat
record
transfus
found
donor
blood
screen
hemoglobin
gdl
hepat
b
viru
hiv
hepat
c
viru
serolog
nucleic
acid
test
neg
syphili
neg
serolog
test
alanin
aminotransferas
iu
merscov
rna
neg
without
contraind
plasmapheresi
donat
sevenday
interv
donat
termin
treatment
aborhd
blood
type
donor
ident
wwwannlabmedorg
http
patient
addit
donor
retrospect
test
presenc
antihla
class
ii
antibodi
antihuman
neutrophil
antigen
hna
antibodi
neg
june
apheresi
perform
ml
plasma
collect
without
advers
effect
donor
patient
receiv
ml
product
immedi
follow
plasma
collect
remain
ml
preserv
later
discard
subsequ
advers
reaction
observ
recipi
collect
plasma
pathogeninactiv
patient
develop
respiratori
distress
within
two
hour
transfus
clinic
laboratori
featur
patient
trali
describ
fig
virolog
aspect
patient
differ
patient
respiratori
symptom
threshold
cycl
ct
valu
merscov
qpcr
perform
patient
lower
respiratori
tract
specimen
show
littl
chang
initi
diagnosi
time
convalesc
plasma
infus
increas
afterward
may
suggest
decreas
viral
load
trali
defin
new
onset
acut
lung
injuri
ali
within
six
hour
transfus
evid
hypoxia
mmhg
room
air
radiolog
evid
addit
requir
evid
left
atrial
hypertens
preexist
ali
tempor
relationship
altern
risk
factor
ali
case
onset
hypoxia
happen
two
hour
convalesc
plasma
infus
oxygen
satur
measur
puls
oximetri
fraction
inspir
oxygen
level
met
criteria
trali
auscult
find
circulatori
overload
trali
suspect
sinc
mer
also
result
ali
recogn
tempor
risk
factor
exist
thu
patient
met
criteria
possibl
trali
antibodi
hla
hna
neg
underli
mechan
thought
nonantibodi
mediat
find
ct
valu
qpcr
increas
transfus
suggest
passiv
immunotherapi
could
decreas
viral
burden
merscov
howev
investig
control
studi
larger
number
subject
requir
determin
clinic
benefit
therapi
blood
compon
donat
precaut
need
prevent
advers
transfus
effect
specif
prevent
antibodymedi
trali
recommend
plasma
process
male
donor
howev
major
potenti
donor
convalesc
plasma
femal
nurs
thu
maleonli
protocol
waiv
mer
outbreak
case
nonhla
antibodymedi
trali
convalesc
plasma
use
ebola
viru
diseas
patient
recent
report
result
convalesc
plasma
infus
mer
patient
led
possibl
trali
suggest
convalesc
plasma
therapi
cautious
approach
especi
regard
possibl
trali
